1. Home
  2. PLRX vs SLND Comparison

PLRX vs SLND Comparison

Compare PLRX & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • SLND
  • Stock Information
  • Founded
  • PLRX 2015
  • SLND 1900
  • Country
  • PLRX United States
  • SLND United States
  • Employees
  • PLRX N/A
  • SLND N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • SLND Military/Government/Technical
  • Sector
  • PLRX Health Care
  • SLND Industrials
  • Exchange
  • PLRX Nasdaq
  • SLND Nasdaq
  • Market Cap
  • PLRX 165.5M
  • SLND 164.0M
  • IPO Year
  • PLRX 2020
  • SLND N/A
  • Fundamental
  • Price
  • PLRX $3.08
  • SLND $3.19
  • Analyst Decision
  • PLRX Buy
  • SLND Buy
  • Analyst Count
  • PLRX 10
  • SLND 2
  • Target Price
  • PLRX $14.86
  • SLND $5.50
  • AVG Volume (30 Days)
  • PLRX 3.4M
  • SLND 23.3K
  • Earning Date
  • PLRX 02-26-2025
  • SLND 03-03-2025
  • Dividend Yield
  • PLRX N/A
  • SLND N/A
  • EPS Growth
  • PLRX N/A
  • SLND N/A
  • EPS
  • PLRX N/A
  • SLND N/A
  • Revenue
  • PLRX N/A
  • SLND $1,029,117,999.00
  • Revenue This Year
  • PLRX N/A
  • SLND N/A
  • Revenue Next Year
  • PLRX N/A
  • SLND $6.18
  • P/E Ratio
  • PLRX N/A
  • SLND N/A
  • Revenue Growth
  • PLRX N/A
  • SLND N/A
  • 52 Week Low
  • PLRX $2.43
  • SLND $1.85
  • 52 Week High
  • PLRX $18.00
  • SLND $6.16
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 22.51
  • SLND 49.31
  • Support Level
  • PLRX $2.92
  • SLND $3.03
  • Resistance Level
  • PLRX $3.16
  • SLND $3.33
  • Average True Range (ATR)
  • PLRX 0.85
  • SLND 0.15
  • MACD
  • PLRX -0.39
  • SLND 0.02
  • Stochastic Oscillator
  • PLRX 6.22
  • SLND 68.68

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.

Share on Social Networks: